Literature DB >> 21807965

Progressive genomic instability in the FVB/Kras(LA2) mouse model of lung cancer.

Minh D To1, David A Quigley, Jian-Hua Mao, Reyno Del Rosario, Jeff Hsu, Graeme Hodgson, Tyler Jacks, Allan Balmain.   

Abstract

Alterations in DNA copy number contribute to the development and progression of cancers and are common in epithelial tumors. We have used array Comparative Genomic Hybridization (aCGH) to visualize DNA copy number alterations across the genomes of lung tumors in the Kras(LA2) model of lung cancer. Copy number gain involving the Kras locus, as focal amplification or whole chromosome gain, is the most common alteration in these tumors and with a prevalence that increased significantly with increasing tumor size. Furthermore, Kras amplification was the only major genomic event among the smallest lung tumors, suggesting that this alteration occurs early during the development of mutant Kras-driven lung cancers. Recurring gains and deletions of other chromosomes occur progressively more frequently among larger tumors. These results are in contrast to a previous aCGH analysis of lung tumors from Kras(LA2) mice on a mixed genetic background, in which relatively few DNA copy number alterations were observed regardless of tumor size. Our model features the Kras(LA2) allele on the inbred FVB/N mouse strain, and in this genetic background, there is a highly statistically significant increase in level of genomic instability with increasing tumor size. These data suggest that recurring DNA copy alterations are important for tumor progression in the Kras(LA2) model of lung cancer and that the requirement for these alterations may be dependent on the genetic background of the mouse strain.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21807965      PMCID: PMC3196775          DOI: 10.1158/1541-7786.MCR-11-0219

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  23 in total

1.  Somatic activation of the K-ras oncogene causes early onset lung cancer in mice.

Authors:  L Johnson; K Mercer; D Greenbaum; R T Bronson; D Crowley; D A Tuveson; T Jacks
Journal:  Nature       Date:  2001-04-26       Impact factor: 49.962

2.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Authors:  E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

3.  Wildtype Kras2 can inhibit lung carcinogenesis in mice.

Authors:  Z Zhang; Y Wang; H G Vikis; L Johnson; G Liu; J Li; M W Anderson; R C Sills; H L Hong; T R Devereux; T Jacks; K L Guan; M You
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

4.  LOH of chromosome 12p correlates with Kras2 mutation in non-small cell lung cancer.

Authors:  Jie Li; Zhongqiu Zhang; Zunyan Dai; Christoph Plass; Carl Morrison; Yian Wang; Jonathan S Wiest; Marshall W Anderson; Ming You
Journal:  Oncogene       Date:  2003-02-27       Impact factor: 9.867

5.  Germline variation controls the architecture of somatic alterations in tumors.

Authors:  Amy M Dworkin; Katie Ridd; Dianne Bautista; Dawn C Allain; O Hans Iwenofu; Ritu Roy; Boris C Bastian; Amanda Ewart Toland
Journal:  PLoS Genet       Date:  2010-09-23       Impact factor: 5.917

6.  Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumors.

Authors:  Christopher S Hackett; J Graeme Hodgson; Mark E Law; Jane Fridlyand; Kazutoyo Osoegawa; Pieter J de Jong; Norma J Nowak; Daniel Pinkel; Donna G Albertson; Ajay Jain; Robert Jenkins; Joe W Gray; William A Weiss
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

7.  Allele-specific Hras mutations and genetic alterations at tumor susceptibility loci in skin carcinomas from interspecific hybrid mice.

Authors:  Hiroki Nagase; Jian-Hua Mao; Allan Balmain
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

Review 8.  Genome amplification of chromosome 20 in breast cancer.

Authors:  J Graeme Hodgson; Koei Chin; Colin Collins; Joe W Gray
Journal:  Breast Cancer Res Treat       Date:  2003-04       Impact factor: 4.872

Review 9.  Chromosome aberrations in solid tumors.

Authors:  Donna G Albertson; Colin Collins; Frank McCormick; Joe W Gray
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

Review 10.  The cancer genome.

Authors:  Michael R Stratton; Peter J Campbell; P Andrew Futreal
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

View more
  15 in total

1.  Statistical thermodynamics of transcription profiles in normal development and tumorigeneses in cohorts of patients.

Authors:  F Remacle; R D Levine
Journal:  Eur Biophys J       Date:  2015-08-20       Impact factor: 1.733

2.  Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinoma.

Authors:  David G McFadden; Katerina Politi; Arjun Bhutkar; Frances K Chen; Xiaoling Song; Mono Pirun; Philip M Santiago; Caroline Kim-Kiselak; James T Platt; Emily Lee; Emily Hodges; Adam P Rosebrock; Roderick T Bronson; Nicholas D Socci; Gregory J Hannon; Tyler Jacks; Harold Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-04       Impact factor: 11.205

3.  Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer.

Authors:  Lisa Maria Mustachio; Yun Lu; Laura J Tafe; Vincent Memoli; Jaime Rodriguez-Canales; Barbara Mino; Pamela Andrea Villalobos; Ignacio Wistuba; Hiroyuki Katayama; Samir M Hanash; Jason Roszik; Masanori Kawakami; Kwang-Jin Cho; John F Hancock; Fadzai Chinyengetere; Shanhu Hu; Xi Liu; Sarah J Freemantle; Ethan Dmitrovsky
Journal:  Mol Cancer Res       Date:  2017-02-27       Impact factor: 5.852

4.  Recombinant cells in the lung increase with age via de novo recombination events and clonal expansion.

Authors:  Takafumi Kimoto; Jennifer E Kay; Na Li; Bevin P Engelward
Journal:  Environ Mol Mutagen       Date:  2017-04       Impact factor: 3.216

5.  CDK2 Inhibition Causes Anaphase Catastrophe in Lung Cancer through the Centrosomal Protein CP110.

Authors:  Shanhu Hu; Alexey V Danilov; Kristina Godek; Bernardo Orr; Laura J Tafe; Jaime Rodriguez-Canales; Carmen Behrens; Barbara Mino; Cesar A Moran; Vincent A Memoli; Lisa Maria Mustachio; Fabrizio Galimberti; Saranya Ravi; Andrew DeCastro; Yun Lu; David Sekula; Angeline S Andrew; Ignacio I Wistuba; Sarah Freemantle; Duane A Compton; Ethan Dmitrovsky
Journal:  Cancer Res       Date:  2015-03-25       Impact factor: 12.701

6.  PIK3CA(H1047R) Accelerates and Enhances KRAS(G12D)-Driven Lung Tumorigenesis.

Authors:  Shon Green; Christy L Trejo; Martin McMahon
Journal:  Cancer Res       Date:  2015-11-13       Impact factor: 12.701

7.  Lung tumourigenesis in a conditional Cul4A transgenic mouse model.

Authors:  Yi-Lin Yang; Ming-Szu Hung; Yang Wang; Jian Ni; Jian-Hua Mao; David Hsieh; Alfred Au; Atul Kumar; David Quigley; Li Tai Fang; Che-Chung Yeh; Zhidong Xu; David M Jablons; Liang You
Journal:  J Pathol       Date:  2014-06       Impact factor: 7.996

8.  Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing.

Authors:  David G McFadden; Thales Papagiannakopoulos; Amaro Taylor-Weiner; Chip Stewart; Scott L Carter; Kristian Cibulskis; Arjun Bhutkar; Aaron McKenna; Alison Dooley; Amanda Vernon; Carrie Sougnez; Scott Malstrom; Megan Heimann; Jennifer Park; Frances Chen; Anna F Farago; Talya Dayton; Erica Shefler; Stacey Gabriel; Gad Getz; Tyler Jacks
Journal:  Cell       Date:  2014-03-13       Impact factor: 41.582

9.  The mutational landscapes of genetic and chemical models of Kras-driven lung cancer.

Authors:  Peter M K Westcott; Kyle D Halliwill; Minh D To; Mamunur Rashid; Alistair G Rust; Thomas M Keane; Reyno Delrosario; Kuang-Yu Jen; Kay E Gurley; Christopher J Kemp; Erik Fredlund; David A Quigley; David J Adams; Allan Balmain
Journal:  Nature       Date:  2014-11-02       Impact factor: 49.962

10.  Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis.

Authors:  M D To; R D Rosario; P M K Westcott; K L Banta; A Balmain
Journal:  Oncogene       Date:  2012-09-03       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.